Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 6
Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
Authors Huynh P, Scott LG, Kwong K
Published 8 February 2010 Volume 2010:6 Pages 65—75
DOI https://doi.org/10.2147/TCRM.S4025
Review by Single anonymous peer review
Peer reviewer comments 4
Peter N Huynh1, Lyne G Scott1, Kenny YC Kwong2
1Division of Allergy-Immunology, Department of Pediatrics, Los Angeles County, University of Southern California Medical Center, Los Angeles, CA, USA; 2Division of Allergy-Immunology, Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, CA, USA
Abstract: Current national and international asthma guidelines recommend treatment of children with asthma towards achieving and maintaining asthma control. These guidelines provide more stringent recommendations to increase therapy for patients with uncontrolled asthma in order to reduce asthma-related morbidity and mortality. Newer combination agents such as budesonide and formoterol have been shown to be safe and effective in treatment of asthma in children. Use of long-term controller agents like this in combination with improved compliance and treatment of co-morbid conditions have been successful in this endeavor. This review discusses control of pediatric asthma with focus on the use of budesonide in combination with formoterol.
Keywords: asthma, control, children, budesonide, formoterol, long-term
© 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.